Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy
José Baselga, Karen A Gelmon, Shailendra Verma, et al.
The British Journal of Surgery
|
March 5, 2025
Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial
Roberto Agresti, Marco Sandri, Giuseppe Capri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer
Luca Gianni, Anna Lladó, Giulia Bianchi, et al.
Medicina (Kaunas, Lithuania)
|
January 25, 2025
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management
Giovanni Paolino, Mario Valenti, Andrea Carugno, et al.
Journal of the Peripheral Nervous System : JPNS
|
September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
Annals of Surgical Oncology
|
November 18, 2025
Sentinel Node Biopsy Alone Versus Sentinel Node Biopsy Plus Axillary Dissection in cT2 cN0/1 Breast Cancer After Neoadjuvant Chemotherapy: 15-Year Results of a Prospective Interventional Study
Gabriele Martelli, Francesco Barretta, Carlo Muzi, et al.
Scientific Reports
|
June 9, 2018
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, et al.
International Journal of Environmental Research and Public Health
|
March 4, 2020
Long-Term Subjective Outcomes of Barbed Reposition Pharyngoplasty for Obstructive Sleep Apnea Syndrome Treatment
Giannicola Iannella, Bianca Vallicelli, Giuseppe Magliulo, et al.
Clinical Breast Cancer
|
January 13, 2019
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles
Claudio Vernieri, Michele Prisciandaro, Monica Milano, et al.
Radiation Oncology (London, England)
|
March 24, 2018
Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer
Laura Lozza, Laura Fariselli, Marco Sandri, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy
José Baselga, Karen A Gelmon, Shailendra Verma, et al.
The British Journal of Surgery
|
March 5, 2025
Axillary surgery versus no-axillary staging in T1N0 breast cancer: 20-year follow-up of the INT 09/98 randomized clinical trial
Roberto Agresti, Marco Sandri, Giuseppe Capri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 4, 2010
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of Pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer
Luca Gianni, Anna Lladó, Giulia Bianchi, et al.
Medicina (Kaunas, Lithuania)
|
January 25, 2025
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management
Giovanni Paolino, Mario Valenti, Andrea Carugno, et al.
Journal of the Peripheral Nervous System : JPNS
|
September 18, 2007
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale
Guido Cavaletti, Barbara Frigeni, Francesca Lanzani, et al.
Annals of Surgical Oncology
|
November 18, 2025
Sentinel Node Biopsy Alone Versus Sentinel Node Biopsy Plus Axillary Dissection in cT2 cN0/1 Breast Cancer After Neoadjuvant Chemotherapy: 15-Year Results of a Prospective Interventional Study
Gabriele Martelli, Francesco Barretta, Carlo Muzi, et al.
Scientific Reports
|
June 9, 2018
The neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict efficacy of platinum-based chemotherapy in patients with metastatic triple negative breast cancer
Claudio Vernieri, Alessia Mennitto, Michele Prisciandaro, et al.
International Journal of Environmental Research and Public Health
|
March 4, 2020
Long-Term Subjective Outcomes of Barbed Reposition Pharyngoplasty for Obstructive Sleep Apnea Syndrome Treatment
Giannicola Iannella, Bianca Vallicelli, Giuseppe Magliulo, et al.
Clinical Breast Cancer
|
January 13, 2019
Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles
Claudio Vernieri, Michele Prisciandaro, Monica Milano, et al.
Radiation Oncology (London, England)
|
March 24, 2018
Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer
Laura Lozza, Laura Fariselli, Marco Sandri, et al.
Page
of 7